The relationship between cardiometabolic Index and diabetic kidney disease in people with diabetes

被引:0
|
作者
Kong, Jianping [1 ]
Tao, Wenting [2 ]
Sun, Yuhong [3 ]
Xu, Yong [4 ,5 ]
Li, Hailun [4 ,5 ]
Li, Jing [4 ,5 ]
机构
[1] Southeast Univ, Nanjing Lishui Peoples Hosp, Zhongda Hosp, Dept Nephrol,Lishui Branch, Nanjing, Peoples R China
[2] Southeast Univ, Nanjing Lishui Peoples Hosp, Zhongda Hosp, Dept Crit Care Med,Lishui Branch, Nanjing, Peoples R China
[3] Sichuan Inst Ind Technol, Sch Phys Educ & Hlth, Dept Nursing, Deyang, Peoples R China
[4] Xuzhou Med Univ, Dept Nephrol, Affiliated Huaian Hosp, Huaian, Peoples R China
[5] Huaian Second Peoples Hosp, Huaian, Peoples R China
来源
关键词
cardiometabolic index; diabetes; diabetic kidney disease; NHANES; adults; OBESITY;
D O I
10.3389/fendo.2024.1376813
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Studies have shown a strong correlation between the cardiometabolic index (CMI) and health issues such as diabetes, atherosclerosis, and decreased renal function. Nevertheless, the correlation between CMI and diabetic kidney disease (DKD) remains ambiguous. The objective of this study is to evaluate the correlation between CMI and DKD in patients with diabetes in the United States. Methods: The study involved individuals who were part of the National Health and Nutrition Examination Survey (NHANES) conducted between 2003 and 2018. A multivariable logistic regression analysis was employed for investigating the correlation between CMI and DKD. The study employed Generalized Additive Models (GAM) and smooth curve fitting methods for investigating the nonlinear relationship between CMI and DKD. Two-stage regression analysis was applied for investigating threshold effects in the connection between CMI and DKD. In addition, subgroup analysis and interaction tests were also carried out. Results: This analysis included a total of 6,540 adults with diabetes. After adjusting for variables including age, sex, race, education level, smoking status, household income and poverty rate, body mass index, hypertension status, aspartate aminotransferase, alanine aminotransferase, serum albumin, and serum globulin, we discovered a significant connection between CMI levels and the risk of DKD (OR=1.11, 95% CI: 1.05, 1.17, p<0.0001). Individuals with varying smoking statuses showed variations in this connection according to subgroup analysis and interaction tests (p for interaction=0.0216). Conversely, this correlation appeared similar across different genders, ages, races, BMI categories, hypertension statuses, and insulin usage among people with diabetes (all p for interaction >0.05). A nonlinear relationship existed between CMI and DKD, with threshold analysis indicating a turning point at CMI=1.7. A positive correlation was observed between CMI levels in people with diabetes and the risk of DKD when CMI exceeded 1.7. Conclusion: The risk of DKD was significantly positively correlated with the CMI levels of people with diabetes. Further larger prospective studies are required to confirm our results.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Study on the association between visceral adiposity index and diabetic kidney disease in hospitalized patients with type 2 diabetes mellitus in China
    Zhao, Xin
    Sun, Jianbin
    Xin, Sixu
    Zhang, Xiaomei
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [42] Editorial: Combating Diabetes and Diabetic Kidney Disease
    Srivastava, Swayam Prakash
    Kanasaki, Keizo
    Goodwin, Julie E.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [43] Relationship between liver and cardiometabolic health in type 1 diabetes
    Tas, Emir
    Vu, Bach-Mai Katherine
    Mendizabal, Brenda
    Libman, Ingrid
    Muzumdar, Radhika
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [44] Body-Weight Cycling and Risk of Diabetic Kidney Disease in People with Type 1 Diabetes
    Camoin, Marion
    Mohammedi, Kamel
    Saulnier, Pierre-Jean
    Hadjadj, Samy
    Gautier, Jean-Francois
    Riveline, Jean-Pierre
    Venteclef, Nicolas
    Potier, Louis
    Velho, Gilberto
    DIABETES, 2024, 73
  • [45] Morphological and functional ultrasound features of diabetic kidney disease phenotypes in people with type 2 diabetes
    Garofolo, M.
    Napoli, V.
    Lucchesi, D.
    Accogli, S.
    Mazzeo, M.
    Rossi, P.
    Falcetta, P.
    Giambalvo, M.
    Neri, E.
    Penno, G.
    Del Prato, S.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S47 - S48
  • [46] Chronic kidney disease prevention campaign: relationship between proteinuria and elderly people
    Nunes Filho, Julio Cesar Chaves
    Camurca, David Silva
    Rocha, Gabriel Alves
    de Oliveira, Ana Beatriz Timbo
    Marinho, Gabriela Correia Pequeno
    Santos, Sergio Gabriel Monteiro
    Pereira, Dyego Castelo Branco Holanda Gadelha
    Meneses, Gdayllon Cavalcante
    Daher, Elizabeth De Francesco
    JORNAL BRASILEIRO DE NEFROLOGIA, 2023, 45 (02): : 162 - 168
  • [47] Liraglutide for the Treatment of Type 2 Diabetes and Safety in Diabetic Kidney Disease: Liraglutide and Diabetic Kidney Disease
    Cherney, David Z.
    Tuttle, Katherine R.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (04): : 444 - 446
  • [48] Kidney Disease in People With Diabetes: The Expanding Epidemic
    Selvin, Elizabeth
    Juraschek, Stephen P.
    Coresh, Josef
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (03) : 340 - 342
  • [49] Prediction of chronic kidney disease in people with diabetes
    Afshar, N.
    Andorra, M.
    Chittajallu, S.
    Huschto, T.
    Babinsky, V.
    Mikulski, H.
    Koenig, H.
    Ringemann, C.
    Odegard, J.
    Singh, I.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 344 - 344
  • [50] Novel Therapies for Kidney Disease in People With Diabetes
    Khurana, Nayana
    James, Steven
    Coughlan, Melinda T.
    MacIsaac, Richard J.
    Ekinci, Elif, I
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (01): : E1 - E24